Commercial due diligence for PE and corporate acquirers
Latchmore’s associate team includes: leaders from PE-owned businesses; big 4 healthcare corporate finance; and strategy consultants with extensive dd experience; as well as executives who can assess the strengths and weaknesses of a potential acquisition or investment.
Assignment: Specialist Radiotherapy
We undertook strategic due diligence of a specialist radiotherapy business on behalf of a trade buyer, including analysis of the vendor due diligence pack and independent market investigation.
Assignment: Pathology Supplies
We undertook a range of UK and International customer interviews on behalf of a PE fund that subsequently invested in a specialist microbiology equipment supplier.
Assignment: PPU Partnership Opportunity
We advised an International hospital group which was considering investing in creating a private patient facility on an NHS hospital site. We undertook a review of demand within the catchment, competition, contractual conditions indicated by the NHS organisation and other commercial opportunities and risks. This led to a decision not to bid.
Assignment: Private Hospital Acquisition
We advised an NHS Acute Organisation, working as part of a larger system, considering acquiring a loss-making private hospital to provide additional capacity. This involved working closely with internal stakeholders to build a financial model and business case, and building consensus on the bid-offer with internal stakeholders. We worked with legal advisers and potential funders to evaluate structuring options and worked with NHS England and their regional teams to build approval for the transaction.
“Weight Partners wanted a very focused commercial due diligence report on a specialist social care investment. Latchmore were able to deliver this with a small number of days and within the timescale dictated by the vendor’s process.”
David Jolly, Managing Partner, Weight Partners Capital LLP
‘’We wanted a rapid analysis of the ophthalmology market, including competitors, consumer trends, pricing and clinical/ technology trends. Latchmore delivered this in a small number of days, and subsequently translated this into the relevant sections of our fundraising documents’’ Henry Pitman, Optimism Health